[{"id":"943dda56-e7f0-4946-96ee-d51318451cb0","acronym":"CAMP1","url":"https://clinicaltrials.gov/study/NCT05698238","created_at":"2023-01-26T16:02:19.184Z","updated_at":"2024-07-02T16:35:53.273Z","phase":"Phase 1","brief_title":"Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours","source_id_and_acronym":"NCT05698238 - CAMP1","lead_sponsor":"Mabpro, a.s.","biomarkers":" CA9","pipe":"","alterations":" ","tags":["CA9"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CA9hu-1"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 01/01/2024","start_date":" 01/01/2024","primary_txt":" Primary completion: 01/01/2026","primary_completion_date":" 01/01/2026","study_txt":" Completion: 01/01/2027","study_completion_date":" 01/01/2027","last_update_posted":"2023-03-15"}]